Xiamen Amoytop Biotech Co Ltd (688278) — Capital Reinvestment Ratio
Xiamen Amoytop Biotech Co Ltd (688278) has a Capital Reinvestment Ratio of 0.13x as of September 2023, meaning it reinvests 0% of its operating cash flow (CN¥332.29 Million) in capital expenditures (CN¥43.00 Million). Check Xiamen Amoytop Biotech Co Ltd (688278) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xiamen Amoytop Biotech Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Xiamen Amoytop Biotech Co Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see Xiamen Amoytop Biotech Co Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for Xiamen Amoytop Biotech Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Xiamen Amoytop Biotech Co Ltd from 2016 to 2024. See 688278 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | CN¥430.63 Million | CN¥251.35 Million | ▲ +22.3% |
| 2023 | 0.48x | CN¥512.10 Million | CN¥244.48 Million | ▼ -20.9% |
| 2022 | 0.60x | CN¥363.16 Million | CN¥219.17 Million | ▼ -25.8% |
| 2021 | 0.81x | CN¥234.78 Million | CN¥190.93 Million | ▼ -36.6% |
| 2020 | 1.28x | CN¥92.61 Million | CN¥118.81 Million | ▲ +252.9% |
| 2019 | 0.36x | CN¥123.30 Million | CN¥44.83 Million | ▲ +122.0% |
| 2018 | 0.16x | CN¥89.15 Million | CN¥14.60 Million | ▼ -92.0% |
| 2016 | 2.05x | CN¥42.43 Million | CN¥87.03 Million | — |